Physician profile
Logan Thomas Smith
NPI 1114615382
$649.63
in general payments reported to CMS, 2019-2025
14 companies · $162 in 2025
The $162 reported for 2025 was less than what a typical Physician Assistant provider received nationally (typical 2025 total: $183).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2023: $80.86 · 2024: $407 · 2025: $162.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $569 · Education: $80.86.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $568.77 |
| Education | $80.86 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Astrazeneca Pharmaceuticals LP | $130.08 | 2024-2025 | Farxiga |
| Kiniksa Pharmaceuticals International, Plc | $104.01 | 2024 | Arcalyst |
| Regeneron Healthcare Solutions, INC. | $80.86 | 2023 | Dupixent |
| Novartis Pharmaceuticals Corporation | $68.13 | 2024-2025 | |
| Depuy Synthes Sales INC. | $44.37 | 2024 | Trufill |
| Pfizer INC. | $42.12 | 2024 | |
| Inari Medical, INC. | $35.12 | 2024 | Ct Thrombectomy System Kit, Flowtriever Catheter, S |
| Kestra Medical Technology Services, INC. | $30.36 | 2025 | Assure Wcd |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $25.25 | 2025 | Lifevest |
| Boehringer Ingelheim Pharmaceuticals, INC. | $21.75 | 2024 | Jardiance |
| Alnylam Pharmaceuticals INC. | $20.00 | 2025 | Onpattro |
| Merck Sharp & Dohme LLC | $18.25 | 2025 | Verquvo |
| Novo Nordisk INC | $15.79 | 2025 | Wegovy |
| Cvrx, INC. | $13.54 | 2024 | Barostim Neo System |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Logan Smith listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.